Clinical trials: sponsored by Bayer

HIV Infections

Phase III Randomized Double-Blind Placebo Controlled Study To Evaluate the Safety and Efficacy of Betaseron in AIDS and Advanced ARC Patients Receiving a Reduced-Dose AZT Regimen

• Completed
• Age: 18 years and older
• Phase 3

To evaluate the safety and efficacy of interferon beta (Betaseron) in AIDS and advanced AIDS related complex (ARC) patients receiving a reduced-dose zidovudine (AZT) regimen.

Trial name

NCT00002238

Testing

Interferon beta-1b, Zidovudine

Where

25 sites in United States

Sponsor

Bayer